Streptococcus Pneumoniae

News Streptococcus Pneumoniae

• Intercell and Boehringer Ingelheim Vetmedica GmbH enter into strategic partnership to develop animal vaccines

  Intercell AG announced that it has entered into a worldwide Option and Exclusive License Agreement under which Boehringer Ingelheim Vetmedica has the right to use certain antigens derived from Intercell’s Antigen Identification Program (AIP®) to develop animal vaccines. Under the agreement, Intercel more

• Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae

  Intercell AG announced results from a Phase I clinical trial investigating the company’s vaccine candidate for the prevention of infections by the bacterium Streptococcus pneumoniae. Intercell’s investigational prophylactic vaccine candidate (IC47) is a recombinant subunit vaccine consisting of thre more

• Novartis gains exclusive worldwide rights to PTK 0796, a potential first-in-class IV and oral broad-spectrum antibiotic

  Novartis has gained exclusive worldwide rights to market PTK 0796, potentially the first once-daily broad-spectrum antibiotic that can be given by intravenous (IV) infusion or oral tablet to treat a wide variety of life-threatening infections, including those caused by highly resistant bacteria such more

Publications Streptococcus Pneumoniae

• Volatile Metabolites of Pathogens: A Systematic Review

  by Lieuwe D. J. Bos, Peter J. Sterk, Marcus J. Schultz Ideally, invading bacteria are detected as early as possible in critically ill patients: the strain of morbific pathogens is identified rapidly, and antimicrobial sensitivity is known well before the start of new antimicrobial therapy. Bacter more

• The role of zinc in the interplay between pathogenic streptococci and their hosts

  Abstract Recent studies on pathogenic streptococci have revealed that zinc is a pivotal metal ion in their interaction with the host. In these streptococci, systems exist that ensure optimal use of zinc from the surrounding milieu, as well as export of zinc when concentrations exceed tolerance l more

• The use of dried cerebrospinal fluid filter paper spots as substrate for PCR diagnosis of the aetiology of bacterial meningitis in the Lao PDR

  Abstract We investigated whether dried cerebrospinal fluid (CSF) conserved on filter paper can be used as a substrate for accurate PCR diagnosis of important causes of bacterial meningitis in the Lao PDR. Using mock CSF, we investigated and optimized filter paper varieties, paper punch sizes, el more

Market studies Streptococcus Pneumoniae

• Streptococcus Pneumoniae (Pneumococcus) Infections – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Streptococcus Pneumoniae (Pneumococcus) Infections - Pipeline Review, H1 2012', provides an overview of the Streptococcus Pneumoniae (Pneumococcus) Infections therapeutic pipeline. This report provides information on the therapeutic development for Streptococ more

• Lipoxen PLC (LPX) - Financial and Strategic SWOT Analysis Review

  Lipoxen PLC (Lipoxen) is a biopharmaceutical company that is engaged in the development of pharmaceutical products in the fields of protein drugs, vaccines and anti-cancer drugs. The company's technologies include PolyXen, a versatile enabling technology that uses the biopolymer polysialic acid to p more

• Xenetic Biosciences plc (XEN) - Financial and Strategic SWOT Analysis Review

  Xenetic Biosciences plc (Xenetic), formerly Lipoxen PLC is a UK-based bio-pharmaceutical company. It engages in the development of pharmaceutical products in the fields of protein drugs, vaccines and anti-cancer drugs. The company's technologies include PolyXen, a versatile enabling technology that more

Websites Streptococcus Pneumoniae